Clover Biopharmaceuticals, Ltd. (2197.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.65B |
| Enterprise Value | 2.39B |
| P/E Ratio | 2.26 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 4,574.5 |
| Price/Book Ratio | -2.36 |
| Enterprise/Revenue | 4,365.6 |
| Enterprise/EBITDA | -7.53 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 1,991.97 |
| Operating Margin | -649.03 |
AD
Management Effectiveness
| Return On Assets | 3.49 |
| Return On Equity | -0.65 |
Income Statement
| Revenue | 3.41M |
| Revenue/Share | 0 |
| Gross Profit | -23.85M |
| EBITDA | -221.24M |
| Net Income | -199.78M |
| Diluted EPS | -0.16 |
Balance Sheet
| Total Cash | 104.77M |
| Total Cash/Share | 0.08 |
| Total Debt | 2.08M |
| Total Debt/Equity | -0 |
| Current Ratio | 0.73 |
| Book Value Per Share | -0.63 |
Price History
| 52-Week Change | -36.55 |
| 52-Week High | 3.2 |
| 52-Week Low | 1.32 |
| Moving Average 50 Days | 2.09 |
| Moving Average 200 Days | 2.24 |
Statistics
| Average Volume | 4.27M |
| Shares Outstanding | 1.3B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
